Н. Б. Чеснокова

536 total citations
57 papers, 390 citations indexed

About

Н. Б. Чеснокова is a scholar working on Ophthalmology, Public Health, Environmental and Occupational Health and Neurology. According to data from OpenAlex, Н. Б. Чеснокова has authored 57 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Ophthalmology, 15 papers in Public Health, Environmental and Occupational Health and 11 papers in Neurology. Recurrent topics in Н. Б. Чеснокова's work include Ocular Surface and Contact Lens (15 papers), Glaucoma and retinal disorders (13 papers) and Retinal Diseases and Treatments (10 papers). Н. Б. Чеснокова is often cited by papers focused on Ocular Surface and Contact Lens (15 papers), Glaucoma and retinal disorders (13 papers) and Retinal Diseases and Treatments (10 papers). Н. Б. Чеснокова collaborates with scholars based in Russia, Tajikistan and United States. Н. Б. Чеснокова's co-authors include О. В. Безнос, О. А. Кост, Natalia L. Klyachko, Е. В. Попова, Alexander N. Vaneev, M. V. Ugrumov, Alexander V. Kabanov, Natalia A. Lozinskaya, Л. А. Катаргина and N. N. Yakhno and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Oxidative Medicine and Cellular Longevity.

In The Last Decade

Н. Б. Чеснокова

50 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Н. Б. Чеснокова Russia 10 127 121 96 85 79 57 390
Jooseppi Puranen Finland 14 82 0.6× 150 1.2× 200 2.1× 127 1.5× 93 1.2× 31 520
О. В. Безнос Russia 8 95 0.7× 86 0.7× 87 0.9× 86 1.0× 67 0.8× 57 324
Nivedita Ravindran United Kingdom 8 49 0.4× 180 1.5× 184 1.9× 48 0.6× 75 0.9× 14 501
Mathieu Schmitt France 6 100 0.8× 28 0.2× 70 0.7× 85 1.0× 51 0.6× 9 299
Tomasz Chorągiewicz Poland 14 54 0.4× 403 3.3× 134 1.4× 25 0.3× 237 3.0× 50 662
R Michael Dutescu Germany 9 118 0.9× 173 1.4× 92 1.0× 48 0.6× 120 1.5× 15 349
Shanmugarathinam Alagarsamy India 10 25 0.2× 16 0.1× 165 1.7× 41 0.5× 28 0.4× 26 413
Basilio Colligris Spain 9 172 1.4× 132 1.1× 97 1.0× 94 1.1× 112 1.4× 18 378
Cem Şimşek Japan 10 304 2.4× 173 1.4× 55 0.6× 54 0.6× 173 2.2× 27 449
Fumiki Shimada Japan 11 33 0.3× 32 0.3× 166 1.7× 8 0.1× 45 0.6× 18 431

Countries citing papers authored by Н. Б. Чеснокова

Since Specialization
Citations

This map shows the geographic impact of Н. Б. Чеснокова's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Н. Б. Чеснокова with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Н. Б. Чеснокова more than expected).

Fields of papers citing papers by Н. Б. Чеснокова

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Н. Б. Чеснокова. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Н. Б. Чеснокова. The network helps show where Н. Б. Чеснокова may publish in the future.

Co-authorship network of co-authors of Н. Б. Чеснокова

This figure shows the co-authorship network connecting the top 25 collaborators of Н. Б. Чеснокова. A scholar is included among the top collaborators of Н. Б. Чеснокова based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Н. Б. Чеснокова. Н. Б. Чеснокова is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Безнос, О. В., et al.. (2023). The rational design of novel 5-amino-2-oxindole derivatives with antiglaucomic activity. Bioorganic & Medicinal Chemistry Letters. 90. 129334–129334. 2 indexed citations
2.
Катаргина, Л. А., et al.. (2023). Enalaprilat as a new means of preventing the development of retinopathy of prematurity. Biomeditsinskaya Khimiya. 69(2). 97–103. 3 indexed citations
3.
Чеснокова, Н. Б., et al.. (2023). Tear fluid as a source of biomarkers for the neurodegeneration in central nervous system. 28(5). 5–13.
4.
Попова, Е. В., О. В. Безнос, Н. Б. Чеснокова, et al.. (2023). A Direct Comparison of Peptide Drug Delivery Systems Based on the Use of Hybrid Calcium Phosphate/Chitosan Nanoparticles versus Unmixed Calcium Phosphate or Chitosan Nanoparticles In Vitro and In Vivo. International Journal of Molecular Sciences. 24(21). 15532–15532. 5 indexed citations
5.
Катаргина, Л. А., et al.. (2023). The role of α2-macroglobulin in endogenous uveitis in children. Russian Ophthalmological Journal. 16(2). 16–21.
6.
Чеснокова, Н. Б., et al.. (2023). Multifunctional Protein Alpha2-Macroglobulin in Tear Fluid and Blood Serum of Patients with Glaucoma. SHILAP Revista de lepidopterología. 19(4). 835–840.
7.
Babkov, Denis A., О. В. Безнос, E. V. Sokolova, et al.. (2023). Microwave-assisted synthesis of 5-aryl-3-hydroxy-2-oxindole derivatives and evaluation of their antiglaucomic activity. Mendeleev Communications. 33(4). 550–552. 3 indexed citations
8.
Катаргина, Л. А., et al.. (2023). The role of endothelin-1 in the pathogenesis of familial exudative vitreoretinopathy. Russian Annals of Ophthalmology. 139(5). 14–14.
9.
Tyurin, V. Yu., et al.. (2022). Antioxidant activity and redox properties of cis-2,4,5-tris(hydroxyaryl)imidazolines. Mendeleev Communications. 32(5). 680–682. 3 indexed citations
10.
Нероев, В. В., et al.. (2022). Impact of fractal visual stimulation on healthy rabbit retina: functional, morphometric and biochemical studies. Russian Ophthalmological Journal. 15(3). 99–111. 5 indexed citations
13.
Безнос, О. В., et al.. (2018). The Inclusion of Timolol and Lisinopril in Calcium Phosphate Particles Covered by Chitosan: Application in Ophthalmology. Moscow University Chemistry Bulletin. 73(2). 85–89. 6 indexed citations
14.
Чеснокова, Н. Б. & О. В. Безнос. (2016). The role of melatonin in the regulation of physiological processes in the eye under normal and pathological conditions and prospects of its application. Russian Ophthalmological Journal. 9(4). 106–111. 1 indexed citations
15.
Безнос, О. В., et al.. (2016). Calcium phosphate particles containing superoxide dismutase are a promising agent for the treatment of eye diseases accompanied by oxidative stress. Moscow University Chemistry Bulletin. 71(3). 154–159. 3 indexed citations
16.
Катаргина, Л. А., et al.. (2016). Melatonin as a new promising agent for the treatment and prevention of retinopathy of prematurity. Russian Annals of Ophthalmology. 132(6). 59–59. 4 indexed citations
17.
Кост, О. А., О. В. Безнос, Devika S. Manickam, et al.. (2015). Superoxide Dismutase 1 Nanozyme for Treatment of Eye Inflammation. Oxidative Medicine and Cellular Longevity. 2016(1). 5194239–5194239. 32 indexed citations
18.
Чеснокова, Н. Б., et al.. (2015). Effects of Hydroxypyridine Derivatives Mexidol and Emoxypin on the Reparative Processes in Rabbit Eye on the Models of Corneal Epithelial Defect and Conjunctival Ischemia. Bulletin of Experimental Biology and Medicine. 158(3). 346–348. 7 indexed citations
19.
Безнос, О. В., et al.. (2012). [Production of timolol containing calcium-phosphate nanoparticles and evaluation of their effect on intraocular pressure in experiment].. PubMed. 128(3). 15–8. 7 indexed citations
20.
Чеснокова, Н. Б., et al.. (1994). Pharmacokinetics of polyvalent proteinase inhibitor (aprotinin) in eye tissues. Documenta Ophthalmologica. 85(3). 275–280. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026